Artificial Intelligence-guided Precision Treatment of High-grade Serous Ovarian Carcinoma

Starting soon

Conditions studied: High-grade Serous Ovarian Carcinoma (HGSOC)

In brief

The subjects of this study are patients with high-grade serous ovarian cancer who have undergone surgical resection. The aim is to construct an artificial intelligence model for predicting postoperative recurrence, metastasis and overall survival of patients based on multimodal data such as surgical pathological images (HE images and IHC images of immune microenvironment-related markers), preoperative baseline imaging data and detailed clinical information of patients. In addition, multi-omics sequencing analysis will be used to deeply explore the heterogeneity of the tumor microenvironment, with the expectation of quantifying the postoperative recurrence risk of patients with high-grade serous ovarian cancer and providing new ideas for the precise diagnosis and treatment of patients with high-grade serous ovarian cancer.

Key facts

Study ID

NCT07721675

Run by

The Affiliated Hospital of Qingdao University

People needed

1300

Starts

2026-08-01

Expected to finish

2027-12-31

Last updated by the study team

2026-07-23

Who can join

Age: 18 and older, up to 80. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Histologically confirmed high-grade serous ovarian carcinoma using resection specimens.
• Well-preserved surgical paraffin-embedded tumor specimens.
• Complete clinical information and survival follow-up data.

You may not qualify if…

• Received preoperative neoadjuvant treatment.
• Poor preservation of surgical paraffin specimens.
• Incomplete clinical information and survival follow-up data.
• With concurrent malignancies other than high-grade serous ovarian carcinoma.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.